drugset / Trial / NCT06654960

Influence of HRS9531 on Pharmacokinetics of Metformin in Healthy Subjects

NCT06654960

Phase 1 Completed 20 enrolled Fujian Shengdi Pharmaceutical Co., Ltd.
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the influence of HRS9531 injection on pharmacokinetics of metformin in healthy subjects.

Timeline

Start
2024-11-05
Primary completion
2024-12-26
Completion
2024-12-26

Drugs

EvaluationDrugModalityDoseRoute
Subject HRS9531 Unknown
Subject Metformin Small molecule 500 mg